Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kowey

Showing results (321-330 of 451) with videos related to

Pageof 46
Sort By:
Clinical Cardiology|January 12, 2022
Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS-ADONIS trialsMunveer Thind, Wojciech Zareba, Dan Atar, et al.
CJC Open|November 11, 2024
Comparing Left Bundle Branch Area vs Right-Ventricular Septal Pacing in High-Degree Conduction Disease After Transcatheter Aortic Valve Replacement: Randomized Trial Study ProtocolSteven Liskov, Farah Olleik, Harish Jarrett, et al.
Journal of the American Heart Association|July 23, 2013
Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registryEmil L Fosbol, DaJuanicia N Holmes, Jonathan P Piccini, et al.
Heart Rhythm|October 8, 2011
Celivarone in patients with an implantable cardioverter-defibrillator: adjunctive therapy for the reduction of ventricular arrhythmia-triggered implantable cardioverter-defibrillator interventionsOlivera Gojkovic, Etienne M Aliot, Alessandro Capucci, et al.
The American Journal of Cardiology|January 11, 1990
Clinical and regulatory implications of the Cardiac Arrhythmia Suppression TrialC M Pratt, D C Brater, F E Harrell, et al.
Cardiology|June 22, 2021
Use of the HAVOC Score to Identify Patients at Highest Risk of Developing Atrial FibrillationMitchell S V Elkind, Rolf Wachter, Atul Verma, et al.
The American Journal of Cardiology|February 27, 2010
The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillationJean-Yves Le Heuzey, Günter Breithardt, John Camm, et al.
Heart Rhythm|February 17, 2015
COR-ART: A multicenter, randomized, double-blind, placebo-controlled dose-ranging study to evaluate single oral doses of vanoxerine for conversion of recent-onset atrial fibrillation or flutter to normal sinus rhythmHoward C Dittrich, Gregory K Feld, Tristram D Bahnson, et al.
American Heart Journal|December 22, 2019
Rhythm monitoring strategies in patients at high risk for atrial fibrillation and stroke: A comparative analysis from the REVEAL AF studyJames A Reiffel, Atul Verma, Peter R Kowey, et al.
The American Journal of Cardiology|April 19, 2017
Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF])Tharian S Cherian, Peter Shrader, Gregg C Fonarow, et al.
Pageof 46

Showing results (321-330 of 451) with videos related to

Sort By:
Pageof 46
Clinical Cardiology|January 12, 2022
Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS-ADONIS trialsMunveer Thind, Wojciech Zareba, Dan Atar, et al.
CJC Open|November 11, 2024
Comparing Left Bundle Branch Area vs Right-Ventricular Septal Pacing in High-Degree Conduction Disease After Transcatheter Aortic Valve Replacement: Randomized Trial Study ProtocolSteven Liskov, Farah Olleik, Harish Jarrett, et al.
Journal of the American Heart Association|July 23, 2013
Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registryEmil L Fosbol, DaJuanicia N Holmes, Jonathan P Piccini, et al.
Heart Rhythm|October 8, 2011
Celivarone in patients with an implantable cardioverter-defibrillator: adjunctive therapy for the reduction of ventricular arrhythmia-triggered implantable cardioverter-defibrillator interventionsOlivera Gojkovic, Etienne M Aliot, Alessandro Capucci, et al.
The American Journal of Cardiology|January 11, 1990
Clinical and regulatory implications of the Cardiac Arrhythmia Suppression TrialC M Pratt, D C Brater, F E Harrell, et al.
Cardiology|June 22, 2021
Use of the HAVOC Score to Identify Patients at Highest Risk of Developing Atrial FibrillationMitchell S V Elkind, Rolf Wachter, Atul Verma, et al.
The American Journal of Cardiology|February 27, 2010
The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillationJean-Yves Le Heuzey, Günter Breithardt, John Camm, et al.
Heart Rhythm|February 17, 2015
COR-ART: A multicenter, randomized, double-blind, placebo-controlled dose-ranging study to evaluate single oral doses of vanoxerine for conversion of recent-onset atrial fibrillation or flutter to normal sinus rhythmHoward C Dittrich, Gregory K Feld, Tristram D Bahnson, et al.
American Heart Journal|December 22, 2019
Rhythm monitoring strategies in patients at high risk for atrial fibrillation and stroke: A comparative analysis from the REVEAL AF studyJames A Reiffel, Atul Verma, Peter R Kowey, et al.
The American Journal of Cardiology|April 19, 2017
Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF])Tharian S Cherian, Peter Shrader, Gregg C Fonarow, et al.
Pageof 46